Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Dri Healthcare Trust
T.DHT.UN
Alternate Symbol(s):
DHTRF
Healthcare
Biotechnology
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence...
in the United States; European Union; Japan, and Rest of the world.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:DHT.UN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Next
(232)
•••
newcoin
X
View Profile
View Bullboard History
Comment by
newcoin
on Mar 11, 2022 12:43am
RE:RBC 2
Amazing price targets. Very exciting to see what they can do. Good Pedegree on this company. They could go all the way.
(6225)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 09, 2022 8:31am
RBC 2
DRI Healthcare Trust Q4/21: Cash royalties and EBITDA ahead of estimates while revenues missed; strong deal pipeline Our view: While Q4/21 royalty income was
...more
Access North American AND Australian listed and Pre-IPO opportunities – here!
posted Dec 27, 2024 9:00am by
Stockhouse Publishing Ltd.
-
|
For the first time on Stockhouse, Canadian investors can access ASX-listed opportunities through our partnership with HotCopper in Australia, opening doors to high-potential investments at the click of a button. Learn more here… ...read more
(1)
•••
cautiousguy
X
View Profile
View Bullboard History
Comment by
cautiousguy
on Mar 09, 2022 12:04am
RE:I’m A New Shareholder And Could Use Help
As you know it's the algorithm you have to watch out for.
(24)
•••
Konaboy
X
View Profile
View Bullboard History
Post by
Konaboy
on Mar 08, 2022 9:27am
NCIB in first year of operation ?!?
That money could fund a 33% dividend boost, which would probably be more appropriate for this venture at this point in time.
(6225)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Mar 08, 2022 8:44am
RBC
March 7, 2022 Outperform TSX: DHT-U; CAD 6.80 Price Target CAD 14.00 DRI Healthcare Trust Q4/21 Cash receipts and adj. EBITDA
...more
(232)
•••
newcoin
X
View Profile
View Bullboard History
Post by
newcoin
on Mar 08, 2022 12:59am
I’m A New Shareholder And Could Use Help
It seems like these are really good results. It seems stable with a safe dividend. Seems like tremendous value. Stock price has gone up recently. I'm happy to be on board but I'm just
...more
(99)
•••
divime1
X
View Profile
View Bullboard History
Post by
divime1
on Mar 07, 2022 7:02pm
News
DRI Healthcare earns $21.56-million (U.S.) in 2021 2022-03-07 17:30 ET - News Release Mr. Behzad Khosrowshahi reports DRI HEALTHCARE TRUST REPORTS FOURTH QUARTER AND
...more
(232)
•••
newcoin
X
View Profile
View Bullboard History
Post by
newcoin
on Mar 01, 2022 10:28am
NR - Approval of Pacritinib/Vonjotm
https://stockhouse.com/news/press-releases/2022/03/01/dri-healthcare-trust-comments-on-fda-approval-of-vonjotm-pacritinib
(8)
•••
hoffbag
X
View Profile
View Bullboard History
Comment by
hoffbag
on Mar 01, 2022 10:03am
RE:Pacritinib Approved
That seems to be waking things up. Now on to the next deal.....
(21)
•••
Muncher
X
View Profile
View Bullboard History
Post by
Muncher
on Feb 28, 2022 7:45pm
Pacritinib Approved
pacritinib approved another 60 million deployed! News release under CTIC
(21)
•••
Muncher
X
View Profile
View Bullboard History
Comment by
Muncher
on Feb 28, 2022 5:45pm
RE:Q4 Numbers - Let’s Get Going
let's hope we get some more details. Bought a few more 1000 shares today. Look forward to earnings!
(232)
•••
newcoin
X
View Profile
View Bullboard History
Post by
newcoin
on Feb 25, 2022 9:27pm
Q4 Numbers - Let’s Get Going
https://stockhouse.com/news/press-releases/2022/02/22/dri-healthcare-trust-to-host-fourth-quarter-earnings-call-and-webcast-on-march-8
(6225)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Feb 17, 2022 6:54am
National Bank All Star
Globe and Mail National Bank reveals its ‘2022 Dividend All-Stars’ DAVID LEEDER PUBLISHED 8 HOURS AGOUPDATED 7 HOURS AGO Equity analysts at National Bank Financial have unveiled their “2022
...more
(12)
•••
raybay_98
X
View Profile
View Bullboard History
Comment by
raybay_98
on Feb 11, 2022 10:26am
RE:Mackenzie Financial exceeded 12.75% of outstanding shares…
Might be 'Flying Under The Radar' as the saying goes. Cann't find anything negative?
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
A potential breakthrough in spinal cord and optic nerve injury treatment
Learn How this Company is Disrupting Point-of-Care Testing